399 filings
Page 8 of 20
6-K
SPRC
SciSparc Ltd
18 Jan 22
SciSparc Advances Its Phase IIb Clinical Trial in Patients with Tourette Syndrome with its Proprietary Drug Candidate SCI-110
4:27pm
6-K
SPRC
SciSparc Ltd
6 Jan 22
Report of Foreign Private Issuer
4:02pm
6-K
SPRC
SciSparc Ltd
6 Jan 22
Current report (foreign)
4:00pm
6-K
SPRC
SciSparc Ltd
6 Jan 22
SciSparc Announces Recruitment of First Patient for its Phase IIa Clinical Trial in Alzheimer’s Disease
9:09am
6-K
SPRC
SciSparc Ltd
4 Jan 22
SciSparc Issued U.S. Patent For Its Core Technology That Treats Central Nervous Systems Disorders
4:42pm
6-K
SPRC
SciSparc Ltd
29 Dec 21
SciSparc Provides Updates Upon Conclusion of 2021
5:12pm
6-K
SPRC
SciSparc Ltd
22 Dec 21
Report of Foreign Private Issuer
4:05pm
CERT
SPRC
SciSparc Ltd
21 Dec 21
Certification of approval for exchange listing
12:30pm
6-K
SPRC
SciSparc Ltd
20 Dec 21
SciSparc Announces Approval of Uplisting to The Nasdaq Capital Market
4:45pm
8-A12B
SPRC
SciSparc Ltd
20 Dec 21
Registration of securities on exchange
4:41pm
EFFECT
SPRC
SciSparc Ltd
20 Oct 21
Notice of effectiveness
12:15am
POS AM
SPRC
SciSparc Ltd
8 Oct 21
Prospectus update (post-effective amendment)
12:00am
6-K
SPRC
SciSparc Ltd
24 Sep 21
Report of Foreign Private Issuer
9:01am
EFFECT
SPRC
SciSparc Ltd
31 Aug 21
Notice of effectiveness
12:15am
EFFECT
SPRC
SciSparc Ltd
31 Aug 21
Notice of effectiveness
12:15am
POS AM
SPRC
SciSparc Ltd
27 Aug 21
Prospectus update (post-effective amendment)
12:00am
POS AM
SPRC
SciSparc Ltd
27 Aug 21
Prospectus update (post-effective amendment)
12:00am
6-K
SPRC
SciSparc Ltd
26 Aug 21
Report of Foreign Private Issuer
5:25pm
6-K/A
SPRC
SciSparc Ltd
26 Aug 21
Current report (foreign) (amended)
4:42pm
6-K
SPRC
SciSparc Ltd
17 Aug 21
Current Report
5:00pm